000 | 01326 a2200349 4500 | ||
---|---|---|---|
005 | 20250515160847.0 | ||
264 | 0 | _c20090402 | |
008 | 200904s 0 0 eng d | ||
022 | _a1699-5848 | ||
024 | 7 |
_a10.14670/HH-24.493 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOkamoto, Kinya | |
245 | 0 | 0 |
_aBiomarkers for novel targeted therapies of hepatocellular carcinoma. _h[electronic resource] |
260 |
_bHistology and histopathology _c04 2009 |
||
300 |
_a493-502 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aBiomarkers, Tumor |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xblood supply |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Neoplasms _xblood supply |
650 | 0 | 4 | _aNeovascularization, Pathologic |
650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
700 | 1 | _aNeureiter, Daniel | |
700 | 1 | _aOcker, Matthias | |
773 | 0 |
_tHistology and histopathology _gvol. 24 _gno. 4 _gp. 493-502 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.14670/HH-24.493 _zAvailable from publisher's website |
999 |
_c18667232 _d18667232 |